We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.87%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$102B
AUM Growth
+$1.43B
(+1.4%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
32.54%
Holding
287
New
14
Increased
80
Reduced
134
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qiagen
QGEN
|
+$518M |
| 2 |
AstraZeneca
AZN
|
+$246M |
| 3 |
Alkermes
ALKS
|
+$172M |
| 4 |
Whirlpool
WHR
|
+$94.4M |
| 5 |
Eli Lilly
LLY
|
+$78.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QGENF
QIAGEN NV
QGENF
|
+$534M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$265M |
| 3 |
Amgen
AMGN
|
+$235M |
| 4 |
NVIDIA
NVDA
|
+$233M |
| 5 |
Microsoft
MSFT
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.81% |
| 2 | Healthcare | 22.95% |
| 3 | Industrials | 16.75% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Financials | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Entegris
ENTG
$22.7B
| $91M | 0.09% |
5,086,052
-13,707
| -0.3% | -$238K |
|
|
NBL
127
DELISTED
Noble Energy, Inc.
NBL
| $86.1M | 0.08% |
2,262,700
-30,300
| -1% | -$1.13M |
|
128
Chegg
CHGG
$96.4M
| $82.9M | 0.08% |
11,232,528
+4,400
| +0% | +$32.8K |
|
129
Stratasys
SSYS
$775M
| $82.9M | 0.08% |
5,010,000
+489,700
| +11% | +$9.6M |
|
130
Sanofi
SNY
$105B
| $82.4M | 0.08% |
2,037,207
| – | – |
|
|
EPZM
131
DELISTED
Epizyme, Inc
EPZM
| $79.2M | 0.08% |
6,543,327
+18,000
| +0.3% | +$188K |
|
132
Comcast
CMCSA
$89.5B
| $79M | 0.08% |
2,289,600
+99,200
| +5% | +$3.31M |
|
133
FormFactor
FORM
$9.32B
| $78.3M | 0.08% |
6,993,918
-1,429,400
| -17% | -$15.2M |
|
134
Western Digital
WDC
$151B
| $77.8M | 0.08% |
1,515,061
-43,205
| -3% | -$1.99M |
|
|
SWN
135
DELISTED
Southwestern Energy Company
SWN
| $77.4M | 0.08% |
7,154,875
+706,250
| +11% | +$8.09M |
|
136
VF Corp
VFC
$5.75B
| $74.7M | 0.07% |
1,487,225
+153,990
| +12% | +$7.99M |
|
|
SREV
137
DELISTED
ServiceSource International, Inc.
SREV
| $73.3M | 0.07% |
12,898,236
| – | – |
|
138
Charles River Laboratories
CRL
$12.6B
| $66.7M | 0.07% |
875,000
-34,660
| -4% | -$2.63M |
|
139
Lowe's Companies
LOW
$124B
| $66.1M | 0.07% |
929,300
| – | – |
|
|
FARO
140
DELISTED
Faro Technologies
FARO
| $65.6M | 0.06% |
1,823,000
| – | – |
|
141
Teradyne
TER
$60.9B
| $65M | 0.06% |
2,557,200
+76,425
| +3% | +$1.81M |
|
142
Waters Corp
WAT
$39.2B
| $63.4M | 0.06% |
471,657
-16,830
| -3% | -$2.4M |
|
143
Gildan
GIL
$10.9B
| $61.7M | 0.06% |
2,431,800
-172,000
| -7% | -$4.58M |
|
|
ASNA
144
DELISTED
Ascena Retail Group, Inc.
ASNA
| $61.2M | 0.06% |
494,205
| – | – |
|
145
Textron
TXT
$15.1B
| $61M | 0.06% |
1,257,000
+222,000
| +21% | +$9.68M |
|
146
Universal Display
OLED
$4.16B
| $60.2M | 0.06% |
1,069,725
+31,125
| +3% | +$1.71M |
|
|
EXAS
147
DELISTED
Exact Sciences
EXAS
| $60M | 0.06% |
4,491,300
| – | – |
|
|
NUVA
148
DELISTED
NuVasive, Inc.
NUVA
| $57.5M | 0.06% |
853,900
-15,100
| -2% | -$973K |
|
149
AbbVie
ABBV
$434B
| $56.5M | 0.06% |
901,845
-52,000
| -5% | -$3.17M |
|
150
IMAX
IMAX
$2.7B
| $56.3M | 0.06% |
1,792,713
+1,377,413
| +332% | +$43M |
|
Similar funds
VAM
Primecap Management's Q4 2016 Portfolio in Review
As of Q4 2016, Primecap Management held 287 positions worth $102B, up 1.4% from $100B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management's Q4 2016 filing shows 14 new, 80 increased, 134 reduced and 11 closed positions. Its largest new stake was Qiagen: 17,384,319 shares worth $536M. The largest sale was QIAGEN NV, an estimated $534M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2016 buy was Qiagen: 17,384,319 shares worth $536M.
- Primecap Management added most to AstraZeneca in Q4 2016, an estimated $246M increase.
- Primecap Management's biggest Q4 2016 reduction was Charles Schwab, cutting an estimated $265M.
- Primecap Management fully exited QIAGEN NV in Q4 2016, selling an estimated $534M.
- Primecap Management's ten largest holdings make up 33% of its $102B portfolio in Q4 2016.
- Primecap Management opened 14 new positions and closed 11 in Q4 2016.
- Primecap Management's portfolio value rose 1.4% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q4 2016, filed 13 Feb 2017.